Rivastigmine Patch 9.5mg/24hrs

Booth No: M426

Characteristic

The Rivastigmine transdermal patch is an enhanced formulation using Transdermal Drug Delivery System (TDDS), indicated for mild to moderate dementia associated with Alzheimer’s disease. It offers sustained drug release while bypassing gastrointestinal and hepatic first-pass metabolism, resulting in improved bioavailability and reduced GI side effects.

Clinical studies confirm bioequivalence to the reference listed drug (RLD). Skin irritation and sensitization evaluations demonstrate a favorable safety profile. Long-term stability data further supports its potential for global commercialization.

Menu

Rivastigmine Patch 9.5mg/24hrs

Characteristic

Other Products

Products you may be interested in

Highest Rated Products